These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38009971)

  • 21. Treatment of agitation and aggression in four demented patients using ECT.
    Grant JE; Mohan SN
    J ECT; 2001 Sep; 17(3):205-9. PubMed ID: 11528314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propofol in the management of postictal delirium with clozapine-electroconvulsive therapy combination.
    Sienaert P; Bouckaert F; Fernandez I; Hagon A; Hagon B; Peuskens J
    J ECT; 2004 Dec; 20(4):254-7. PubMed ID: 15591860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) - a promising option.
    Glass OM; Forester BP; Hermida AP
    Int Psychogeriatr; 2017 May; 29(5):717-726. PubMed ID: 28095946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series.
    Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI
    J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postictal excitement following bilateral and right-unilateral ECT.
    Sackeim HA; Decina P; Malitz S; Hopkins N; Yudofsky SC; Prohovnik I
    Am J Psychiatry; 1983 Oct; 140(10):1367-8. PubMed ID: 6624976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation.
    Brydges D; Tibrewal P; Waite S; Dhillon R
    Aust N Z J Psychiatry; 2016 Apr; 50(4):386-7. PubMed ID: 26508796
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of increased anesthetic dose prior to electroconvulsive therapy to prevent postictal excitement.
    Devanand DP; Sackeim HA
    Gen Hosp Psychiatry; 1992 Sep; 14(5):345-9. PubMed ID: 1521790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
    Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder: a perspective from anesthesiologists.
    Küçük A; Karababa F; Yüce HH; Yalçin S
    J ECT; 2013 Sep; 29(3):249. PubMed ID: 23965607
    [No Abstract]   [Full Text] [Related]  

  • 32. Disappearance of akathisia following electroconvulsive treatment.
    De Keyser J; D'Haenen H
    Clin Neuropharmacol; 1986; 9(6):563-5. PubMed ID: 3802108
    [No Abstract]   [Full Text] [Related]  

  • 33. Etomidate-Induced Convulsions During Electroconvulsive Therapy: Two Case Reports.
    Bruylandt R; Van den Abbeele D; Jacobs T; Wouters P; Audenaert K; Lemmens G
    J ECT; 2016 Mar; 32(1):73-4. PubMed ID: 26207533
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anesthesia for electroconvulsive therapy: clinical experience].
    González AG; Cortínez LI; De la Cuadra JC; Carrasco E; Rioseco A; Léniz P
    Rev Esp Anestesiol Reanim; 2007; 54(7):414-20. PubMed ID: 17953335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence of Postictal α/β Activity During Maintenance Course of Electroconvulsive Therapy.
    Schultz K; Tham J; Chan P; Brenner C; Northcott C; Vila-Rodriguez F
    J ECT; 2015 Dec; 31(4):211-2. PubMed ID: 25764162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.
    Acharya D; Harper DG; Achtyes ED; Seiner SJ; Mahdasian JA; Nykamp LJ; Adkison L; Van der Schuur White L; McClintock SM; Ujkaj M; Davidoff DA; Forester BP
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):265-73. PubMed ID: 24838521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing adverse outcomes of unmodified electroconvulsive therapy: suggestions and possibilities.
    Gallegos J; Vaidya P; D'Agati D; Jayaram G; Nguyen T; Tripathi A; Trivedi JK; Reti IM
    J ECT; 2012 Jun; 28(2):77-81. PubMed ID: 22531198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propofol and electroconvulsive therapy in a patient at risk from acute intermittent porphyria.
    Shaw IH; McKeith IG
    Br J Anaesth; 1998 Feb; 80(2):260-2. PubMed ID: 9602601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant effect of the first electroconvulsive therapy with ketamine and/or propofol.
    Kellner CH; Briggs MC; Pasculli RM; Bryson EO
    J ECT; 2013 Jun; 29(2):149. PubMed ID: 23703230
    [No Abstract]   [Full Text] [Related]  

  • 40. Antidepressant effect of the first electroconvulsive therapy with ketamine and/or propofol: response.
    Wang X
    J ECT; 2013 Jun; 29(2):149. PubMed ID: 23703231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.